BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25894803)

  • 1. Next generation of weight management medications: implications for diabetes and CVD risk.
    Wharton S; Serodio KJ
    Curr Cardiol Rep; 2015 May; 17(5):35. PubMed ID: 25894803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications for weight loss.
    Mordes JP; Liu C; Xu S
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):91-7. PubMed ID: 25692921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs.
    Drolet B; Simard C; Poirier P
    Am J Cardiovasc Drugs; 2007; 7(4):273-88. PubMed ID: 17696568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
    Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological therapies to address obesity in type 1 diabetes.
    Casu A; Bilal A; Pratley RE;
    Curr Opin Endocrinol Diabetes Obes; 2020 Aug; 27(4):194-206. PubMed ID: 32618631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
    Burguera B; Ali KF; Brito JP
    Cleve Clin J Med; 2017 Jul; 84(7 Suppl 1):S39-S46. PubMed ID: 28708481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options.
    Andrew CA; Saunders KH; Shukla AP; Aronne LJ
    Expert Opin Pharmacother; 2019 Apr; 20(5):585-593. PubMed ID: 30614740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for obesity.
    Dickerson LM; Carek PJ
    Am Fam Physician; 2000 Apr; 61(7):2131-8, 2143. PubMed ID: 10779254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity.
    Saunders KH; Kumar RB; Igel LI; Aronne LJ
    Curr Atheroscler Rep; 2016 Jul; 18(7):36. PubMed ID: 27181165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of obesity in cardiovascular disease.
    Charakida M; Finer N
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 14. Current and Future Medical Treatment of Obesity.
    Umashanker D; Igel LI; Kumar RB; Aronne LJ
    Gastrointest Endosc Clin N Am; 2017 Apr; 27(2):181-190. PubMed ID: 28292399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we need anti-obesity drugs?
    Hainer V; Hainerová IA
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
    Caterson ID; Finer N
    Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity medications and the treatment of type 2 diabetes.
    Greenway F
    Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel anti-obesity drugs].
    Tripp B; Ludvik B
    Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on obesity pharmacotherapy.
    Velazquez A; Apovian CM
    Ann N Y Acad Sci; 2018 Jan; 1411(1):106-119. PubMed ID: 29377198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.